Brief: Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test
17/12/2025 01:17
Dec 17 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX: US PATENT SECURED FOR PROMARKERESO DIAGNOSTIC TEST FOR ESOPHAGEAL ADENOCARCINOMA Further company coverage: PIQ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Says Restructure, Executive Appointment And Board Update
Brief: Proteomics International Laboratories Says Canadian Patent Secured For Promarkereso Diagnostic Test For Esophageal Adenocarcinoma
Appointment Of CEO And Managing Director
Brief: Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test
Proteomics at 9-month high on securing US patent for diagnostic test